Could a $4 statin be the migraine cure We've been missing?

NCT ID NCT06248671

Recruiting now Disease control Sponsor: St. Olavs Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 15, 2026 · Updated 2 times

Summary

This study tests whether atorvastatin, a common cholesterol medicine, can prevent migraine attacks in adults with episodic migraine (4-14 attacks per month). Researchers will compare a 20mg dose, a 40mg dose, and a placebo over several months. The goal is to see if the drug reduces the number of migraine days and is safe, building on promising results from smaller studies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPISODIC MIGRAINE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

migraine disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

EPISODIC MIGRAINE

Contacts and locations

Locations

Haukeland University Hospital
RECRUITING

Bergen, Norway
Oslo University Hospital, Rikshospitalet
NOT_YET_RECRUITING

Oslo, Norway
Oslo University Hospital, Ullevål
NOT_YET_RECRUITING

Oslo, Norway
St. Olavs hospital
RECRUITING

Trondheim, 7022, Norway
University Hospital Northern Norway
RECRUITING

Tromsø, Norway
University Hospital, Akershus
NOT_YET_RECRUITING

Lørenskog, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.